PROgnosticating COeliac patieNts SUrvivaL: The PROCONSUL score

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Biagi, Federico ^a   Schiepatti, Annalisa ^a   Malamut, Georgia ^b   Marchese, Alessandra ^a   Cellier, Christophe ^b   Bakker, Sjoerd F ^c   Mulder, Chris J J ^c   Volta, Umberto ^d   Zingone, Fabiana ^e   Ciacci, Carolina ^e   D'Odorico, Anna ^f   Andrealli, Alida ^g   Astegiano, Marco ^g   Klersy, Catherine ^h   Corazza, Gino R ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY OF SALERNO   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

^h FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CASE-CONTROL STUDIES; CELIAC DISEASE; DELAYED DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84894289333     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084163     Document Type: Article

References (22)

1. Dubé C, Rostom A, Sy R, Cranney A, Saloojee N, et al. (2005) The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 128 (4 Suppl 1): S57-67. (Pubitemid 40460823)
2. Biagi F, Gobbi P, Marchese A, Borsotti E, Zingone F, et al. (2013) Low incidence but poor prognosis of complicated coeliac disease: a retrospective multicentre study. Dig Liver Dis http://dx.doi.org/10.1016/j.dld.2013.10.010.
3. Biagi F, Corazza GR (2010) Mortality in celiac disease. Nat Rev Gastroenterol Hepatol 7: 158-162.
4. Biagi F, Lorenzini P, Corazza GR, Literature review on the clinical relationship between ulcerative jejunoileitis, coeliac disease, and enteropathy-associated T-cell (2000) Scand J Gastroenterol 35: 785-790.
5. Mearin ML, Catassi C, Brousse N, Brand R, Collin P, et al. (2006) European multi-centre study on coeliac disease and non-Hodgkin lymphoma. Eur J Gastroenterol Hepatol 18: 187-194. (Pubitemid 43361605)
6. Malamut G, Cellier C (2011) Is refractory celiac disease more severe in old Europe? Am J Gastroenterol 106: 929-932.
7. West J (2009) Celiac disease and its complications: a time traveller's perspective. Gastroenterology 136: 32-34.
8. Roshan B, Leffler DA, Jamma S, Dennis M, Shets S, et al (2011) The incidence and clinical spectrum of refractory celiac disease in a north american referral center. Am J Gastroenterol 106: 923-928.
9. Di Sabatino A, Biagi F, Gobbi PG, Corazza GR (2012) How I treat enteropathy-associated T-cell lymphoma. Blood 119: 2458-2468.
10. Malamut G, Afchain P, Verkarre V, Lecomte T, Amiot A, et al. (2009) Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 136: 81-90.
11. Al-Toma A, Verbeek WH, Hadithi M, von Blomberg BM, Mulder CJ (2007) Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut 56: 1373-1378. (Pubitemid 47517830)
12. Daum S, Ipczynski R, Schumann M, Wahnschaffe U, Zeitz M (2009) High rates of complications and substantial mortality in both types of refractory sprue. Eur J Gastroenterol Hepatol 21: 66-70.
13. Rubio-Tapia A, Kelly DG, Lahr BD, Dogan A, Wu TT, et al. (2009) Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology 136: 99-107.
14. Gale J, Simmonds PD, Mead GM, Sweetenham JW, Wright DH (2000) Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol 18: 795-803. (Pubitemid 30106610)
15. Corrao G, Corazza GR, Bagnardi V, Brusco G, Ciacci C, et al. (2001) Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 358: 356-361. (Pubitemid 32739095)
16. Murray JA, Moore SB, Van Dyke CT, Lahr BD, Dierkhising RA, et al. (2007) HLA DQ gene dosage and risk and severity of celiac disease. Clin Gastroenterol Hepatol 5: 1406-1412. (Pubitemid 350181596)
17. Al-Toma A, Goerres MS, Meijer JWR, Peña AS, Crusius JB, et al. (2006) Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy associated T-cell lymphoma. Clin Gastroenterol Hepatol 4: 315-319. (Pubitemid 43343887)
18. Biagi F, Bianchi PI, Vattiato C, Marchese A, Trotta L, et al. (2012) The influence of HLA-DQ2 and DQ8 on severity in celiac disease. J Clin Gastroenterol 46: 46-50.
19. Ludvigsson JF, Leffler DA, Bai J, Biagi F, Fasano A, et al. (2013) The Oslo definitions for coeliac disease and related terms. Gut 62: 43-52.
20. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49: 1373-1379. (Pubitemid 27028925)
21. Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA (2013) ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 108: 656-676.
22. Peters U, Askling J, Gridley G, Ekbom A, Linet M (2003) Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 163: 1566-1572. (Pubitemid 36835101)